Carlyle Group Inc. Portfolio Holdings

Carlyle Group Inc.

  • $1.36 Billion
  • Q1 2024

Carlyle Group Inc. has filed its 13F form on May 03, 2024 for Q1 2024 where it was disclosed a total value porftolio of $1.36 Billion distributed in 32 stocks.

Among their holdings, we can observe that their the top five positions include companies like: Quidel Ortho Corp with a value of $597M, Zoom Info Technologies Inc. with a value of $421M, Vitru LTD with a value of $94M, Verona Pharma PLC with a value of $39.5M, and Vector Holding, LLC with a value of $38.2M.

Examining the 13F form we can see an decrease of $602M in the current position value, from $1.96B to 1.36B.

Carlyle Group Inc. is based out at Washington, DC

Below you can find more details about Carlyle Group Inc. portfolio as well as his latest detailed transactions.

Portfolio value $1.36 Billion
Healthcare: $719 Million
Technology: $451 Million
Consumer Defensive: $99.2 Million
Communication Services: $38.8 Million
Real Estate: $27 Million
Industrials: $18.3 Million
Consumer Cyclical: $3.17 Million
Financial Services: $863,000
Other: $0

Stock Holdings Table

Stock Market Cap. Holding Value (Reported) # of Shares. Last Trade Trade History
$2.87B
$597 Million 43.98% of portfolio
12,460,183
Q2 2022 New
$5.28B
$421 Million 30.98% of portfolio
26,244,474
Q1 2024 Reduced 25.54%
$282M
$94 Million 6.92% of portfolio
6,246,471
Q3 2020 New
$792M
$39.5 Million 2.91% of portfolio
2,457,500
Q1 2023 New
$1.21B
$38.2 Million 2.82% of portfolio
9,212,799
Q1 2024 Reduced 1.93%
$413M
$37.1 Million 2.73% of portfolio
3,496,808
Q2 2023 Added 19.14%
$529M
$30.6 Million 2.25% of portfolio
1,838,486
Q1 2023 New
$1.81B
$27.1 Million 1.99% of portfolio
4,072,624
Q1 2023 Added 7.81%
$354M
$18.3 Million 1.35% of portfolio
1,314,164
Q2 2023 Added 0.01%
$21.7B
$17 Million 1.25% of portfolio
477,500
Q1 2023 New
$9.96B
$9.97 Million 0.73% of portfolio
220,500
Q3 2022 New
$64M
$6.93 Million 0.51% of portfolio
2,948,718
Q1 2024 Added 39.39%
$2.02B
$5.19 Million 0.38% of portfolio
340,748
Q1 2024 New
$42.8M
$4.48 Million 0.33% of portfolio
2,698,957
Q2 2023 Added 30.14%
$300M
$3.17 Million 0.23% of portfolio
4,810,209
Q2 2022 New
$17.7M
$2.29 Million 0.17% of portfolio
2,896,518
Q1 2023 New
$2.3B
$1.23 Million 0.09% of portfolio
93,732
Q1 2024 New
$565B
$1 Million 0.07% of portfolio
755
Q1 2024 New
$41.5B
$863,000 0.06% of portfolio
72,341
Q1 2024 New
$186M
$866,000 0.06% of portfolio
3,333,333
Q1 2023 New
$42B
$572,000 0.04% of portfolio
4,156
Q1 2024 New
$4.55B
$234,000 0.02% of portfolio
7,683
Q1 2024 New
$2.48M
$168,000 0.01% of portfolio
281,636
Q1 2023 New
Complete Solaria Inc
-
$0 0.0% of portfolio
-
Q1 2024 Added 79.78%
Spyre Therapeutics Inc
-
$0 0.0% of portfolio
-
Q4 2023 New
Meta Data Limited
-
$0 0.0% of portfolio
-
Q2 2022 New
Soleno Therapeutics Inc
-
$0 0.0% of portfolio
-
Q1 2024 Added 42.47%
Molecular Templates Inc
-
$0 0.0% of portfolio
-
Q3 2023 New
Q32 Bio Inc
-
$0 0.0% of portfolio
-
Q1 2024 New
Effector Therapeutics Inc
-
$0 0.0% of portfolio
-
Q1 2024 New
Jasper Therapeutics Inc
-
$0 0.0% of portfolio
-
Q1 2024 New

Summary

  • Portfolio
  • No. of Stocks 32
  • Current Value $1.36 Billion
  • Prior Value $1.96 Billion
  • Filing
  • Period Q1 2024
  • Filing Date May 03, 2024
  • Form Type 13F-HR
  • Activity in Q1 2024
  • New Purchases 10 stocks
  • Additional Purchases 3 stocks
  • Sold out of 0 stocks
  • Reduced holdings in 2 stocks
Track This Portfolio

Track Carlyle Group Inc. Portfolio

Follow Carlyle Group Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Carlyle Group Inc., based on Form 13F filings with the SEC.

News

Stay updated on Carlyle Group Inc. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email